Genetics and tailored therapy in cardiovascular disease

about

Cardiovascular genetics: technological advancements and applicability for dilated cardiomyopathy

P2860

Q38511012-2C37F4DB-D472-4F1C-B82A-A7167EF7C11B

P2860

Genetics and tailored therapy in cardiovascular disease

Item

http://www.wikidata.org/entity/Q35638586

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Genetics and tailored therapy in cardiovascular disease

@ast

Genetics and tailored therapy in cardiovascular disease

@en

type

Item

label

Genetics and tailored therapy in cardiovascular disease

@ast

Genetics and tailored therapy in cardiovascular disease

@en

prefLabel

Genetics and tailored therapy in cardiovascular disease

@ast

Genetics and tailored therapy in cardiovascular disease

@en

P1476

Genetics and tailored therapy in cardiovascular disease

@en

P2093

F W Asselbergs

http://www.w3.org/2001/XMLSchema#string

P A Doevendans

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenetics, pharmacogenomics, and individualized medicine

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

Cardiovascular risk associated with interactions among polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems

Unravelling the pathophysiology of heart failure through human genomics.

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study.

CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.

The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.

Evaluation of newborn screening bloodspot-based genetic testing as second tier screen for bedside newborn hearing screening.

P2888

s12471-011-0231-0

P304

3-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1007/S12471-011-0231-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51870797

http://www.w3.org/2001/XMLSchema#string

P698

22160993

http://www.w3.org/2001/XMLSchema#string

P932

3247633

http://www.w3.org/2001/XMLSchema#string

Genetics and tailored therapy in cardiovascular disease

about

P2860

P2860

Genetics and tailored therapy in cardiovascular disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932